1. Difference in microRNA expression and editing profile of lung tissues from different pig breeds related to immune responses to HP-PRRSV
    Jia Li et al, 2015, Sci Rep CrossRef
  2. MiR-143 and rat embryo implantation
    Shi Tian et al, 2015, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  3. MicroRNA-143 promotes cardiac ischemia-mediated mitochondrial impairment by the inhibition of protein kinase Cepsilon
    Hong Hong et al, 2017, Basic Res Cardiol CrossRef
  4. cfa-miR-143 Promotes Apoptosis via the p53 Pathway in Canine Influenza Virus H3N2-Infected Cells
    Pei Zhou et al, 2017, Viruses CrossRef
  5. Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia
    Jin-Long Huang et al, 2017 CrossRef
  6. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia
    Despina Piatopoulou et al, 2018, Ann Hematol CrossRef
  7. The reciprocal link between EVI1 and miRNAs in human malignancies
    Wen-Jing Lang et al, 2018, Gene CrossRef
  8. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
    Jens-Uwe Hartmann et al, 2018, Cell Death Dis CrossRef
  9. OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia
    Chengcheng He et al, 2018, Leukemia & Lymphoma CrossRef
  10. MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential
    Rajab Mardani et al, 2018, J Cell Physiol CrossRef
  11. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
    Wafaa M. Rashed et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
  12. Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment
    Yuki Yoshikawa et al, 2019, Molecular Therapy - Methods & Clinical Development CrossRef
  13. Single Nucleotide Polymorphisms in MIR143 Contribute to Protection Against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations
    Gabrielle Bradshaw et al, 2019, Genes CrossRef
  14. Liposome-coated lipoplex–based carrier for antisense oligonucleotides
    Paulina Wyrozumska et al, 2015, Cancer Biology & Therapy CrossRef
  15. Rare Variants of ATG5 Are Likely to Be Associated With Chinese Patients With Systemic Lupus Erythematosus
    Yue-miao Zhang et al, 2015, Medicine CrossRef
  16. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia
    Ying-ying Zhang et al, 2015, Leukemia Research CrossRef
  17. Changes in apoptotic microRNA and mRNA expression profiling inCaenorhabditis elegansduring the Shenzhou-8 mission
    Ying Gao et al, 2015, J Radiat Res CrossRef
  18. Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis
    Ani V. Das et al, 2015, Cancer Cell Int CrossRef
  19. MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells
    Jing Liu et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  20. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration
    Ntube N.O. Ngalame et al, 2016, Toxicology and Applied Pharmacology CrossRef
  21. Embryonic atrazine exposure alters zebrafish and human miRNAs associated with angiogenesis, cancer, and neurodevelopment
    Sara E. Wirbisky et al, 2016, Food and Chemical Toxicology CrossRef
  22. Sperm microRNA Content Is Altered in a Mouse Model of Male Obesity, but the Same Suite of microRNAs Are Not Altered in Offspring’s Sperm
    Tod Fullston et al, 2016, PLoS ONE CrossRef
  23. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2
    Shun Ke et al, 2017, Int J Hematol CrossRef
  24. Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
    Li Yang et al, 2019, Front. Oncol. CrossRef
  25. Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury
    Sanchari Roy et al, 2016 CrossRef
  26. miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
    Nicola Amodio et al, 2015, Oncotarget CrossRef
  27. MicroRNA‑143 increases cell apoptosis in myelodysplastic syndrome through the Fas/FasL pathway both in�vitro and in�vivo
    Jiaqi Cui et al, 2018, Int J Oncol CrossRef
  28. MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics
    Anna Sadakierska-Chudy, 2020, Biomolecules CrossRef
  29. Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
    Marco Benati et al, 2015 CrossRef
  30. Evidence that dysplasia related microRNAs in Barrett’s esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma
    Juanjuan Xu et al, 2020, Aging CrossRef
  31. Synthetic MIR143-3p Suppresses Cell Growth in Rhabdomyosarcoma Cells by Interrupting RAS Pathways Including PAX3–FOXO1
    Nobuhiko Sugito et al, 2020, Cancers CrossRef
  32. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
    Yammy Yung et al, 2021, IJMS CrossRef
  33. MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy
    Yalda Baghay Esfandyari et al, 2021, Reprod. Sci. CrossRef
  34. A Unified Computational Framework for a Robust, Reliable, and Reproducible Identification of Novel miRNAs From the RNA Sequencing Data
    Vivek Ruhela et al, 2022, Front. Bioinform. CrossRef
  35. MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools
    Ioannis Kyriakidis et al, 2022, Cancers CrossRef
  36. Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia
    Małgorzata Dawidowska et al, 2022, IJMS CrossRef
  37. Evaluation of miR-143 rs4705342 and miR-222 rs2858060 genetic variants in patients with acute myeloid leukemia
    Roxana Mehrpour et al, 2022, Human Gene CrossRef
  38. null
    Harinder Gill et al, 2023 CrossRef
  39. The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients
    Zahra Abrehdari-Tafreshi et al, 2024, Biochem Genet CrossRef